Skip to content

AOCI at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$1.37B+3.8%
Gilead Sciences logo
Gilead SciencesGILD
$78M-15.2%
AbbVie logo
AbbVieABBV
-$1.15B+33.8%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$70K-6.1%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$586K+124%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$11K-97.9%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's AOCI?
RNTX (RNTX) reported AOCI of -$62K in Q1 2026.
How has RNTX's AOCI changed year-over-year?
RNTX's AOCI decreased by 93.8% year-over-year, from -$32K to -$62K.
What is the long-term trend for RNTX's AOCI?
Over 5 years (2020 to 2025), RNTX's AOCI has grown at a 98.7% compound annual growth rate (CAGR), from -$2K to -$62K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.